MET - MetLife Inc

https://www.metlife.com

Hold Momentum: Bearish

Recent News

MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan

Zacks Commentary • 1 week, 3 days ago • score: 0.04

MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management experts for patients starting in 2026.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with 90 million customers in over 60 countries.

52W High

$87.16

52W Low

$64.24

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.86

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

13.50

Forward P/E (<15 better)

8.05

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

0.94

P/S (TTM) (<3 favorable)

0.72

P/B (<3 favorable)

1.91

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.25%

Institutions (25–75% balanced)

91.61%

Shares Outstanding

665,026,000

Float

554,692,000

Dividend Yield (2–6% sweet spot)

0.03%

Ex‑Dividend Date

2025-08-05

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

73,011,003,000

Gross Profit (TTM)

18,783,001,000

EPS (TTM)

5.89

Profit Margin (>10% good)

0.06%

Operating Margin (TTM) (higher better)

0.06%

ROE (TTM) (>15% strong)

0.16%

EPS YoY (Quarterly) (>10% good)

-0.20

Revenue YoY (Quarterly) (>8% good)

-0.03

Momentum

Bearish momentum

Value

0.7592

0.7214

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025